T 2220/14 (VelocImmune mouse/REGENERON) of 9.11.2015

European Case Law Identifier: ECLI:EP:BA:2015:T222014.20151109
Date of decision: 09 November 2015
Case number: T 2220/14
Application number: 02709544.7
IPC class: C12N 15/00
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 970 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: METHODS OF MODIFYING EUKARYOTIC CELLS
Applicant name: REGENERON PHARMACEUTICALS, INC.
Opponent name: Kymab Limited
Merus B.V.
Novo Nordisk A/S
Board: 3.3.08
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 83
European Patent Convention Art 84
European Patent Convention Art 123(2)
European Patent Convention Art 123(3)
Rules of procedure of the Boards of Appeal Art 12(4)
Rules of procedure of the Boards of Appeal Art 13(1)
Rules of procedure of the Boards of Appeal Art 13(3)
Keywords: Postponement of the oral proceedings - (no)
Admission of documents (139), (161), (169) to (172) and (175) - (no)
Admission of documents (156), (158) and (168) - (yes)
Reopening debate - (no)
Confidentiality of documents (169) to (172) - (yes)
Admission of main request filed at the oral proceedings - (yes)
Requirements of the EPC fulfilled - (yes)
Catchwords:

Sufficiency of disclosure - see sections 55 to 72

Cited decisions:
G 0007/93
T 0012/81
T 0056/87
T 0158/91
T 0452/91
T 0612/92
T 0694/92
T 0639/95
T 1149/97
T 1119/05
T 1621/09
T 0161/11
Citing decisions:
T 1596/16
T 2015/20

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t142220eu1.html

Date retrieved: 17 May 2021

19 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law